Literature DB >> 20956833

Imaging for the diagnosis and management of ductal carcinoma in situ.

Carl J D'Orsi1.   

Abstract

Diagnosis of ductal carcinoma in situ (DCIS) has increased dramatically in parallel with the increased use of screening mammography. There are specific mammographic findings, most associated with shapes (amorphous, fine and coarse pleomorphic, and fine linear) and distributions (linear and segmental) of calcifications that permit a reasonable sensitivity for detection of DCIS without an unreasonable decrease in specificity, especially in view of the dramatic decrease in breast cancer mortality associated with early detection. While some DCIS may never progress to invasive disease, at this time, we cannot make that separation. This should be an active area for research.

Entities:  

Mesh:

Year:  2010        PMID: 20956833      PMCID: PMC5161079          DOI: 10.1093/jncimonographs/lgq037

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  12 in total

1.  Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations.

Authors:  Béatrice Barreau; Isabelle de Mascarel; Caroline Feuga; Gaétan MacGrogan; Marie-Hélène Dilhuydy; Véronique Picot; Jean-Marie Dilhuydy; Christine Tunon de Lara; Emmanuel Bussières; I Schreer
Journal:  Eur J Radiol       Date:  2005-04       Impact factor: 3.528

2.  Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.

Authors: 
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

3.  In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.

Authors:  M Blichert-Toft; H P Graversen; J Andersen; U Dyreborg; A Green
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

4.  Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy.

Authors:  W A Berg; C L Arnoldus; E Teferra; M Bhargavan
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

5.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

Authors:  B Fisher; J Dignam; N Wolmark; D L Wickerham; E R Fisher; E Mamounas; R Smith; M Begovic; N V Dimitrov; R G Margolese; C G Kardinal; M T Kavanah; L Fehrenbacher; R H Oishi
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

6.  Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.

Authors:  D Rosner; R N Bedwani; J Vana; H W Baker; G P Murphy
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

7.  New Swedish breast cancer detection results for women aged 40-49.

Authors:  L Tabar; S W Duffy; L W Burhenne
Journal:  Cancer       Date:  1993-08-15       Impact factor: 6.860

8.  Comparison of acquisition parameters and breast dose in digital mammography and screen-film mammography in the American College of Radiology Imaging Network digital mammographic imaging screening trial.

Authors:  R Edward Hendrick; Etta D Pisano; Alice Averbukh; Catherine Moran; Eric A Berns; Martin J Yaffe; Benjamin Herman; Suddhasatta Acharyya; Constantine Gatsonis
Journal:  AJR Am J Roentgenol       Date:  2010-02       Impact factor: 3.959

9.  The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.

Authors:  L Liberman; A F Abramson; F B Squires; J R Glassman; E A Morris; D D Dershaw
Journal:  AJR Am J Roentgenol       Date:  1998-07       Impact factor: 3.959

10.  Incidence of and treatment for ductal carcinoma in situ of the breast.

Authors:  V L Ernster; J Barclay; K Kerlikowske; D Grady; C Henderson
Journal:  JAMA       Date:  1996-03-27       Impact factor: 56.272

View more
  6 in total

1.  Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain.

Authors:  Laia Domingo; Anabel Romero; Francesc Belvis; Mar Sánchez; Joana Ferrer; Dolores Salas; Josefa Ibáñez; Alfonso Vega; Francesc Ferrer; M Soledad Laso; Francesc Macià; Xavier Castells; Maria Sala
Journal:  Eur Radiol       Date:  2011-05-11       Impact factor: 5.315

2.  Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.

Authors:  Fresia Pareja; David N Brown; Ju Youn Lee; Arnaud Da Cruz Paula; Pier Selenica; Rui Bi; Felipe C Geyer; Andrea Gazzo; Edaise M da Silva; Mahsa Vahdatinia; Anthe A Stylianou; Lorenzo Ferrando; Hannah Y Wen; James B Hicks; Britta Weigelt; Jorge S Reis-Filho
Journal:  Clin Cancer Res       Date:  2020-03-27       Impact factor: 12.531

3.  Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.

Authors:  Min Sun Bae; Woo Kyung Moon; Jung Min Chang; Nariya Cho; So Yeon Park; Jae-Kyung Won; Yoon-Kyung Jeon; Hyeong-Gon Moon; Wonshik Han; In Ae Park
Journal:  Eur Radiol       Date:  2013-03-20       Impact factor: 5.315

4.  Deposition of calcium in an in vitro model of human breast tumour calcification reveals functional role for ALP activity, altered expression of osteogenic genes and dysregulation of the TRPM7 ion channel.

Authors:  Shane O'Grady; Maria P Morgan
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

5.  Educational Case: Ductal Carcinoma In Situ (DCIS).

Authors:  Miglena K Komforti; Bryan E Harmon
Journal:  Acad Pathol       Date:  2019-11-21

6.  A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast.

Authors:  Luca Nicosia; Anna Carla Bozzini; Silvia Penco; Chiara Trentin; Maria Pizzamiglio; Matteo Lazzeroni; Germana Lissidini; Paolo Veronesi; Gabriel Farante; Samuele Frassoni; Vincenzo Bagnardi; Cristiana Fodor; Nicola Fusco; Elham Sajjadi; Enrico Cassano; Filippo Pesapane
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.